Literature DB >> 32441211

A Bayesian approach for analyzing partly interval-censored data under the proportional hazards model.

Chun Pan1, Bo Cai2, Lianming Wang3.   

Abstract

Partly interval-censored time-to-event data often occur in biomedical studies of diseases where periodic medical examinations for symptoms of interest are necessary. Recent decades have seen blooming methods and R packages for interval-censored data; however, the research effort for partly interval-censored data is limited. We propose an efficient and easy-to-implement Bayesian semiparametric method for analyzing partly interval-censored data under the proportional hazards model. Two simulation studies are conducted to compare the performance of the proposed method with two main Bayesian methods currently available in the literature and the classic Cox proportional hazards model. The proposed method is applied to a partly interval-censored progression-free survival data from a metastatic colorectal cancer trial.

Entities:  

Keywords:  Bayesian semiparametric; partly interval-censored; progression-free survival; proportional hazards model

Mesh:

Year:  2020        PMID: 32441211      PMCID: PMC7592883          DOI: 10.1177/0962280220921552

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  13 in total

1.  Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

Authors:  Marc Peeters; Timothy Jay Price; Andrés Cervantes; Alberto F Sobrero; Michel Ducreux; Yevhen Hotko; Thierry André; Emily Chan; Florian Lordick; Cornelis J A Punt; Andrew H Strickland; Gregory Wilson; Tudor-Eliade Ciuleanu; Laslo Roman; Eric Van Cutsem; Valentina Tzekova; Simon Collins; Kelly S Oliner; Alan Rong; Jennifer Gansert
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

2.  A semiparametric probit model for case 2 interval-censored failure time data.

Authors:  Xiaoyan Lin; Lianming Wang
Journal:  Stat Med       Date:  2010-01-12       Impact factor: 2.373

3.  Generalized log-rank tests for partly interval-censored failure time data.

Authors:  Xingqiu Zhao; Qiang Zhao; Jainguo Sun; Jong S Kim
Journal:  Biom J       Date:  2008-06       Impact factor: 2.207

4.  Multiple frailty model for clustered interval-censored data with frailty selection.

Authors:  Chun Pan; Bo Cai; Lianming Wang
Journal:  Stat Methods Med Res       Date:  2015-03-19       Impact factor: 3.021

5.  Semiparametric estimation of the accelerated failure time model with partly interval-censored data.

Authors:  Fei Gao; Donglin Zeng; Dan-Yu Lin
Journal:  Biometrics       Date:  2017-04-25       Impact factor: 2.571

6.  A Bayesian proportional hazards model for general interval-censored data.

Authors:  Xiaoyan Lin; Bo Cai; Lianming Wang; Zhigang Zhang
Journal:  Lifetime Data Anal       Date:  2014-08-07       Impact factor: 1.588

7.  Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer.

Authors:  M Peeters; T J Price; A Cervantes; A F Sobrero; M Ducreux; Y Hotko; T André; E Chan; F Lordick; C J A Punt; A H Strickland; G Wilson; T E Ciuleanu; L Roman; E Van Cutsem; Y Tian; R Sidhu
Journal:  Ann Oncol       Date:  2014-01       Impact factor: 32.976

8.  Semiparametric bayes' proportional odds models for current status data with underreporting.

Authors:  Lianming Wang; David B Dunson
Journal:  Biometrics       Date:  2010-12-22       Impact factor: 2.571

9.  Effects of mid-point imputation on the analysis of doubly censored data.

Authors:  C G Law; R Brookmeyer
Journal:  Stat Med       Date:  1992-09-15       Impact factor: 2.373

10.  Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: The interval R package.

Authors:  Michael P Fay; Pamela A Shaw
Journal:  J Stat Softw       Date:  2010-08       Impact factor: 6.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.